SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (476)12/12/2003 12:40:46 PM
From: Icebrg  Read Replies (3) of 631
 
>>Funny I don't see anything in the initial PR about having no expectations :-)>>

Maybe because at that time she tried to pretend that psoriasis was a very promising indication for Humax-CD4.

Genmab's psoriasis project is now its lead program. "The psoriasis data in the Phase II [study] is much more promising. We have some efficacy and a dose-response curve," Drakeman said.

findarticles.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News